Interest of Colchicine for the Treatment of Cystic Fibrosis Patients. Preliminary Report
Cystic fibrosis (CF) lung disease is characterized by persistent inflammation. Antiinflammatory drugs, such as corticosteroids and ibuprofene, have proved to slow the decline of pulmonary function although their use is limited because of frequent adverse events. We hypothesized that colchicine could...
Saved in:
| Main Authors: | I. Sermet-Gaudelus, V. Stoven, J. P. Annereau, V. Witko-Sarsat, P. Reinert, M. Guyot, B. Descamps-Latscha, J. Y. Lallemand, G. Lenoir |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1999-01-01
|
| Series: | Mediators of Inflammation |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09629359990667 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Impact of CFTR Modulators on Longitudinal Cystic Fibrosis Survival and Mortality: Review and Secondary Analysis
by: Jaime L. Rubin, et al.
Published: (2025-07-01) -
Aquagenic Wrinkling of the Palms in a Patient with Cystic Fibrosis
by: Inês Aparício Martins, et al.
Published: (2025-02-01) -
India: The Last and Best Frontier for Cystic Fibrosis Newborn Screening with Perspectives on Special Challenges
by: Philip M. Farrell, et al.
Published: (2025-04-01) -
Phenotype and Genotype of Two Taiwanese Cystic Fibrosis Siblings and a Survey of Delta F508 in East Asians
by: Chao-Jen Lin, et al.
Published: (2008-12-01) -
Time to replace the oral glucose tolerance test for cystic fibrosis related diabetes first-step screening? Establishing glycemic tools relevant to cystic fibrosis
by: Mathew P. Estey, et al.
Published: (2025-12-01)